Publications by authors named "Richard Barron"

Claim this Profile
P
Predictors of imminent risk of fracture in Medicare-enrolled men and women.
Akeem A Yusuf, Yan Hu, David Chandler, Daria B Crittenden, Richard L Barron

Arch Osteoporos· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validated prediction of imminent risk of fracture for older adults.
Richard L Sheer, Richard L Barron, Lavanya Sudharshan, Margaret K Pasquale

Am J Manag Care· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative dose intensity of first-line chemotherapy and overall survival in patients with advanced non-small-cell lung cancer.
Jeffrey Crawford, Neelima Denduluri, Debra Patt, Xiaolong Jiao, Phuong Khanh Morrow, Richard Barron

Support Care Cancer· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Designing effective capstone experiences and projects for entry-level doctoral students in occupational therapy: One program's approaches and lessons learned.
Sara Stephenson, Oaklee Rogers, Cynthia Ivy, Richard Barron, Jennifer Burke

Open J Occup Ther· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Imminent Risk of Nonvertebral Fracture in Older, High-Risk Women: The Framingham Osteoporosis Study.
Marian T Hannan, Derek Weycker, Robert R McLean, Shivani Sahni, Rebecca Bornheimer, Richard Barron

JBMR Plus· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical Costs for Osteoporosis-Related Fractures in High-Risk Medicare Beneficiaries.
Kandice A Kapinos, Shira H Fischer, Andrew Mulcahy, Orla Hayden, Richard Barron

J Am Geriatr Soc· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy Dose Intensity and Overall Survival Among Patients With Advanced Breast or Ovarian Cancer.
Neelima Denduluri, Gary H Lyman, Yunfei Wang, Phuong Khanh Morrow, Richard Barron

Clin Breast Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United States.
Emily Durden, Lionel Pinto, Lorena Lopez-Gonzalez, Paul Juneau, Richard Barron

Arch Osteoporos· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospitalizations, outcomes, and management costs of febrile neutropenia in patients from a managed care population.
Aniket A Kawatkar, Albert J Farias, Chun Chao, Wansu Chen, Richard Barron

Support Care Cancer· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Model for Assessing the Clinical and Economic Benefits of Bone-forming Agents for Reducing Fractures in Postmenopausal Women at High, Near-term Risk of Osteoporotic Fracture.
Claire E O'Hanlon, Anju Parthan, Morgan Kruse, Shannon Cartier, Bjorn Stollenwerk, Richard Barron

Clin Ther· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma.
Kelly Fust, Xiaoyan Li, Michael Maschio, Guillermo Villa, Anju Parthan, Richard Barron

Pharmacoeconomics· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of osteoporosis medication after a fragility fracture among elderly Medicare beneficiaries.
Akeem A Yusuf, Thomas J Matlon, Andreas Grauer, Richard Barron, David Chandler

Arch Osteoporos· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbidities among patients with cancer who do and do not develop febrile neutropenia during the first chemotherapy cycle.
Xiaoyan Li, Rakesh Luthra, Phuong K Morrow, Maxine D Fisher, Maureen Reiner, Richard L Barron

J Oncol Pharm Pract· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials.
Li Wang, Onur Baser, Lucie Kutikova, John H Page, Richard Barron

Support Care Cancer· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices.
Neelima Denduluri, Debra A Patt, Yunfei Wang, Menaka Bhor, Xiaoyan Li, Richard L Barron

J Natl Compr Canc Netw· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of colony-stimulating factors in febrile neutropenia prophylaxis: how results are affected by research design.
Henry J Henk, Xiaoyan Li, Laura K Becker, Hairong Xu, Qi Gong, Richard L Barron

J Comp Eff Res· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer chemotherapy treatment patterns and febrile neutropenia in the US Veterans Health Administration.
Li Wang, Richard Barron, Onur Baser, Wendy J Langeberg, David C Dale

Value Health· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings.
Derek Weycker, Richard Barron, Alex Kartashov, Jason Legg, Gary H Lyman

J Oncol Pharm Pract· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulocyte colony-stimulating factor (G-CSF) patterns of use in cancer patients receiving myelosuppressive chemotherapy.
Mi Rim Choi, Craig A Solid, Victoria M Chia, Anne H Blaes, John H Page, Richard Barron

Support Care Cancer· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of prophylaxis treatment strategies for febrile neutropenia in patients with recurrent ovarian cancer.
Kelly Fust, Xiaoyan Li, Michael Maschio, Richard Barron, Milton C Weinstein

Gynecol Oncol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discrete choice experiment to estimate breast cancer patients' preferences and willingness to pay for prophylactic granulocyte colony-stimulating factors.
Phaedra Johnson, Tim Bancroft, Richard Barron, Jason Legg, Xiaoyan Li

Value Health· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropenia.
Brian Dulisse, Xiaoyan Li, Julie A Gayle, Richard L Barron, Frank R Ernst

J Med Econ· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary vs secondary prophylaxis with pegfilgrastim for the reduction of febrile neutropenia risk in patients receiving chemotherapy for non-Hodgkin's lymphoma: cost-effectiveness analyses.
Gregory Hill, Richard Barron, Kelly Fust, Michelle E Skornicki, Douglas C A Taylor

J Med Econ· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective study of patients' out-of-pocket costs for granulocyte colony-stimulating factors.
Karen Tomic, Stacey Long, Xiaoyan Li, An-Chen Fu, Tzy-Chyi Yu, Richard Barron

J Oncol Pharm Pract· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in neutropenia-related inpatient events.
Chris M Kozma, Michael Dickson, Victoria Chia, Jason Legg, Richard Barron

J Oncol Pract· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis